ARHGAP10 and breast carcinoma: In summary, the expression of ARHGAP10 is downregulated in breast cancer, and relative low expression of ARHGAP10 is correlated with malignant characteristics such as a high Ki-67 index, advanced cTNM stage, poor response to chemotherapy and low RFS rates.